FTI 277 HCl

Catalog No.S7465 Batch:S746502

Print

Technical Data

Formula

C22H30ClN3O3S2
Molecular Weight 484.07 CAS No. 180977-34-8
Solubility (25°C)* In vitro DMSO 96 mg/mL (198.31 mM)
Water 96 mg/mL (198.31 mM)
Ethanol 96 mg/mL (198.31 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description FTI 277 HCl is a potent and selective farnesyltransferase (FTase) inhibitor with IC50 of 500 pM, about 100-fold selectivity over the closely related GGTase I. FTI 277 HCl inhibits cell growth and induces apoptosis. FTI 277 HCl is effective in clearing HDV viremia.
Targets
FTase [1]
(Cell-free assay)
500 pM
In vitro

FTI-277 inhibits Ras processing with an IC50 of 100 nM, but not the geranylgeranylated Rap1A processing in whole cells. FTI-277 induces accumulation of cytoplasmic non-farnesylated H-Ras, accumulates inactive Ras/Raf complexes in the cytoplasm, and blocks constitutive MAPK activation in H-RasF cells. [1] FTI-277 causes increased apoptosis after irradiation and increases radiosensitivity in H-ras-transformed rat embryo cells. [2] FTI-277 also inhibits cell growth and induces apoptosis in drug-resistant myeloma tumor cells. [3] In SH-SY5Y cells, FTI-277 diminishes the toxic effects of methamphetamine on induction in cell degeneration, activation in c-Jun-N-terminal kinase cascades, and Ras activation. [4]
In vivo

In mice coinfected with hepatitis B virus (HBV) and HDV, FTI-277 (50 mg/kg/d i.p.) effectively clears HDV viremia. [5]

Protocol (from reference)

Kinase Assay:

[1]
  • FTase and GGTase I Activity Assay

    FTase and GGTase I activities from 60,000×g supernatants of human Burkitt lymphoma (Daudi) cells are assayed. Inhibition studies are performed by determining the ability of Ras CAAX peptidomimetics to inhibit the transfer of [3H]farnesyl and [3H]geranylgeranyl from [3H]farnesylpyrophosphate and [3H]geranylgeranylpyrophosphate to H-Ras-CVLS and H-Ras-CVLL, respectively.
Cell Assay:

[3]
  • Cell lines

    8226, U266, and H929 multiple myeloma cell lines

  • Concentrations

    ~10 μM

  • Incubation Time

    96 hours

  • Method

    Cells are seeded at 8000–14 000 cells/well in 96-well plates. To establish a dose–response to FTI-277, cells are incubated for 96 h in two-fold serial dilutions ranging from 3.75 times 10-7 M to 1 times 10-5 M. Following continuous drug exposure, 50 μL MTT dye is added. The insoluble formazan complex is solubilized with DMSO and absorbance measured at 540 nm. IC50s and 95% confidence intervals are calculated by regression analysis of the linear portion of the dose–response curve.
Animal Study:

[5]
  • Animal Models

    HBV/HDV-transgenic FVB mice

  • Dosages

    50 mg/kg/d

  • Administration

    i.p.

Customer Product Validation

Data from [Data independently produced by , , Cancer Lett, 2018, 442:202-212]

Selleck's FTI 277 HCl has been cited by 10 publications

Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma [ Cancer Res, 2023, 83(13):2248-2261] PubMed: 37057874
Farnesyl pyrophosphate is a new danger signal inducing acute cell death [ PLoS Biol, 2021, 19(4):e3001134] PubMed: 33901180
Mevalonate Pathway-mediated ER Homeostasis Is Required for Haploid Stability in Human Somatic Cells [ Cell Struct Funct, 2021, 46(1):1-9] PubMed: 33361684
Cellular basis underlying the intolerance to haploidy in vertebrates [ HOKKAIDO UNIVERSITY, 2021, 10.14943/doctoral.k14392] PubMed: None
LUBAC controls chromosome alignment by targeting CENP-E to attached kinetochores [ Nat Commun, 2019, 10(1):273] PubMed: 30655516
FBXW7 regulates endothelial barrier function by suppression of the cholesterol synthesis pathway and prenylation of RhoB [ Mol Biol Cell, 2019, 30(5):607-621] PubMed: 30601691
Zoledronic acid enhances the efficacy of the MEK inhibitor trametinib in KRAS mutant cancers [Dai X, et al. Cancer Lett, 2018, 442:202-212] PubMed: 30429107
Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cells. [ Oncol Rep, 2018, 40(4):2171-2182] PubMed: 30106444
Inhibition of YAP reverses primary resistance to EGFR inhibitors in colorectal cancer cells [ Oncol Rep, 2018, 40(4):2171-2182] PubMed: 30106444
Palmitoylated SCP1 is targeted to the plasma membrane and negatively regulates angiogenesis [ Elife, 2017, 6e22058] PubMed: 28440748

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.